Postpartum hemorrhage (PPH), defined as blood loss after vaginal or cesarean delivery, is the leading cause of maternal deaths especially in developing and under developed countries. Primary PPH is characterized by blood loss that occurs within 24 hours of delivery and secondary PPH if the blood loss occurs after 24 hours of delivery. Poor uterine conditions, which include failure of uterus to contract after childbirth is primarily the reason for PPH and thus, the demand for modern PPH treatment devices outpace the traditional methods, due to the fact that these devices aim toward healing the uterine conditions and problems of uterus contractions.
Rise in incidence of PPH cases, increase in awareness regarding PPH risk factors, and surge in pregnancy related complications drive the growth of the market. Moreover, increase in number of education and training initiatives by the government on PPH propels the growth of this market. However, lack of awareness in developing countries about the available devices and low adoption of PPH devices in these countries restrain the growth of the market.
Postpartum hemorrhage device market is segmented on the basis of on product and region. Product segment is classified into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is fragmented into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major companies profiled in this report include, 3rd Stone Design, Bactiguard AB, Becton, Dickinson and company Clinical Innovations, LLC., Cook, Obstetrx, Organon, Path, Teleflex Incorporated, Utah Medical Products, Inc., and Zoex.
Rise in incidence of PPH cases, increase in awareness regarding PPH risk factors, and surge in pregnancy related complications drive the growth of the market. Moreover, increase in number of education and training initiatives by the government on PPH propels the growth of this market. However, lack of awareness in developing countries about the available devices and low adoption of PPH devices in these countries restrain the growth of the market.
Postpartum hemorrhage device market is segmented on the basis of on product and region. Product segment is classified into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is fragmented into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major companies profiled in this report include, 3rd Stone Design, Bactiguard AB, Becton, Dickinson and company Clinical Innovations, LLC., Cook, Obstetrx, Organon, Path, Teleflex Incorporated, Utah Medical Products, Inc., and Zoex.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the postpartum hemorrhage devices industry, market segments, current trends, estimations, and dynamics of the postpartum hemorrhage (pph) devices market analysis from 2020 to 2030 to identify the prevailing postpartum hemorrhage devices market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the postpartum hemorrhage (pph) devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global postpartum hemorrhage devices industry, market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Non-Pneumatic Anti-Shock Garment
- Prefilled Injection System
- Uterine Tamponade Devices
- Foley Catheter
- Condom Catheter
- Balloon Tamponade
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Germany
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Utah Medical Products, Inc.
- BD
- Cook
- Teleflex Incorporated
- BACTIGUARD AB
- PATH
- 3rd Stone Design
- ZOEX
- ORGANON
- OBSTETRX
- Clinical Innovations, LLC.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY PRODUCT
CHAPTER 5: POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET, BY REGION
CHAPTER 6: COMPANY LANDSCAPE
CHAPTER 7: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Postpartum Hemorrhage (PPH) Devices Market,' the postpartum hemorrhage devices market size was valued at $797.32 million in 2020, and is estimated to reach $1.3 billion by 2030, growing at a CAGR of 5.3% from 2021 to 2030.PPH is defined as the excess amount of blood loss (more than 500 ml) after the delivery of child from vagina, uterus, cervix, and perineum. Increase in incidence of pregnancy-related complications, including multiple pregnancies, inverted uterus, large baby size, surge in risk factors, which causes PPH, including uterine atony, trauma, retained placenta, and bleeding disorders, and technological advancements in the recently approved devices drive the postpartum hemorrhage devices market growth. However, lack of trained professionals and healthcare services in developing countries hampers the market growth.
Postpartum hemorrhage devices industry is segmented on the basis of on product and region. Product segment is classified into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is further divided into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Region-wise, North America dominated the postpartum hemorrhage devices market in 2020, and is expected to be dominant during the forecast period, owing to rise in the PPH cases and availability of advanced healthcare facilities. However, Asia-Pacific is expected to register highest CAGR of 6.4% from 2021 to 2030, owing to increase in rate of anemia among women in the region, which, in turn, increases the risk of postpartum hemorrhage. In addition, rise in awareness about PPH complications and increase in healthcare expenditure fuel the growth of global PPH device market.
Key findings of the Study
- The study provides an in-depth postpartum hemorrhage devices market analysis, and the current trends & future estimations to elucidate imminent investment pockets.
- By product, the uterine balloon tamponade segment accounted for the largest postpartum hemorrhage devices market share in 2020.
- Region-wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the postpartum hemorrhage devices market forecast.
Companies Mentioned
- Utah Medical Products, Inc.
- BD
- Cook
- Teleflex Incorporated
- BACTIGUARD AB
- PATH
- 3rd Stone Design
- ZOEX
- ORGANON
- OBSTETRX
- Clinical Innovations, LLC.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
